Lynn Paxton

9.0k total citations · 2 hit papers
49 papers, 4.6k citations indexed

About

Lynn Paxton is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Lynn Paxton has authored 49 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 25 papers in Epidemiology and 16 papers in Virology. Recurrent topics in Lynn Paxton's work include HIV/AIDS Research and Interventions (34 papers), HIV, Drug Use, Sexual Risk (22 papers) and HIV Research and Treatment (16 papers). Lynn Paxton is often cited by papers focused on HIV/AIDS Research and Interventions (34 papers), HIV, Drug Use, Sexual Risk (22 papers) and HIV Research and Treatment (16 papers). Lynn Paxton collaborates with scholars based in United States, Uganda and Thailand. Lynn Paxton's co-authors include Roman Gvetadze, Maria J. Wawer, Nelson K. Sewankambo, Lisa A. Grohskopf, Philip A. Mock, Pravan Suntharasamai, Suphak Vanichseni, Janet M. McNicholl, Sithisat Chiamwongpaet and Udomsak Sangkum and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Lynn Paxton

48 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

2013 1.1k citations Kachit Choopanya, Michael Martin et al. The Lancet profile →
Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial

1999 589 citations Maria J. Wawer, Nelson K. Sewankambo et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lynn Paxton United States	27	3.5k	2.4k	1.2k	1.1k	1.1k	49	4.6k
Thomas Lutalo United States	7	3.3k 0.9×	1.9k 0.8×	1.4k 1.2×	1.7k 1.4×	730 0.7×	7	4.3k
Eduard J. Sanders Kenya	42	4.5k 1.3×	2.9k 1.2×	1.5k 1.2×	1.4k 1.2×	1.3k 1.2×	196	5.9k
Anatoli Kamali Uganda	39	2.9k 0.8×	1.7k 0.7×	1.9k 1.5×	907 0.8×	766 0.7×	146	4.7k
Timothy D. Mastro United States	49	4.8k 1.4×	3.2k 1.3×	1.3k 1.1×	3.0k 2.6×	895 0.8×	148	7.1k
Anne Buvé Belgium	41	2.6k 0.7×	1.8k 0.7×	2.0k 1.6×	579 0.5×	976 0.9×	117	4.7k
R A Coutinho Netherlands	44	2.6k 0.7×	3.1k 1.3×	624 0.5×	1.9k 1.6×	488 0.4×	154	5.9k
Francis Martinson United States	33	2.1k 0.6×	1.6k 0.7×	1.4k 1.1×	705 0.6×	432 0.4×	92	3.8k
Robert W. Ryder United States	36	2.5k 0.7×	1.8k 0.7×	1.2k 1.0×	745 0.6×	405 0.4×	62	4.7k
Cheryl Baxter South Africa	24	3.0k 0.8×	1.9k 0.8×	1.2k 1.0×	1.1k 0.9×	403 0.4×	74	4.1k
Walter Jaoko Kenya	36	1.9k 0.5×	1.6k 0.7×	910 0.7×	1.3k 1.1×	570 0.5×	231	4.7k

Countries citing papers authored by Lynn Paxton

Since Specialization

Citations

This map shows the geographic impact of Lynn Paxton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Paxton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Paxton more than expected).

Fields of papers citing papers by Lynn Paxton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn Paxton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Paxton. The network helps show where Lynn Paxton may publish in the future.

Co-authorship network of co-authors of Lynn Paxton

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn Paxton. A scholar is included among the top collaborators of Lynn Paxton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn Paxton. Lynn Paxton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ngondi, Jeremiah, Deus S. Ishengoma, Stephanie M. Doctor, et al.. (2017). Surveillance for sulfadoxine-pyrimethamine resistant malaria parasites in the Lake and Southern Zones, Tanzania, using pooling and next-generation sequencing. Malaria Journal. 16(1). 236–236. 19 indexed citations

Ali, Abdullah, Mwinyi Msellem, Issa Garimo, et al.. (2017). Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar. Malaria Journal. 16(1). 332–332. 8 indexed citations

Suntharasamai, Pravan, Michael Martin, Kachit Choopanya, et al.. (2015). Assessment of Oral Fluid HIV Test Performance in an HIV Pre-Exposure Prophylaxis Trial in Bangkok, Thailand. PLoS ONE. 10(12). e0145859–e0145859. 16 indexed citations

Martin, Michael, Suphak Vanichseni, Pravan Suntharasamai, et al.. (2015). The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs. AIDS. 29(7). 819–824. 79 indexed citations

Niska, Richard W, Charles E. Rose, Faith L. Henderson, et al.. (2014). Bone Mineral Density Changes among HIV-Uninfected Young Adults in a Randomised Trial of Pre-Exposure Prophylaxis with Tenofovir-Emtricitabine or Placebo in Botswana. PLoS ONE. 9(3). e90111–e90111. 61 indexed citations

Segolodi, Tebogo, Faith L. Henderson, Charles E. Rose, et al.. (2014). Normal Laboratory Reference Intervals among Healthy Adults Screened for a HIV Pre-Exposure Prophylaxis Clinical Trial in Botswana. PLoS ONE. 9(4). e93034–e93034. 19 indexed citations

Grohskopf, Lisa A., Kata Chillag, Roman Gvetadze, et al.. (2013). Randomized Trial of Clinical Safety of Daily Oral Tenofovir Disoproxil Fumarate Among HIV-Uninfected Men Who Have Sex With Men in the United States. JAIDS Journal of Acquired Immune Deficiency Syndromes. 64(1). 79–86. 136 indexed citations

Philpott, Sean, et al.. (2010). The challenge of defining standards of prevention in HIV prevention trials. Journal of Medical Ethics. 37(4). 244–248. 17 indexed citations

Kim, Susan C., Stephen Becker, Carl W. Dieffenbach, et al.. (2010). Planning for pre‐exposure prophylaxis to prevent HIV transmission: challenges and opportunities. Journal of the International AIDS Society. 13(1). 24–24. 41 indexed citations

10.

Garcı́a-Lerma, J. Gerardo, Lynn Paxton, Peter H. Kilmarx, & Walid Heneine. (2009). Oral pre-exposure prophylaxis for HIV prevention. Trends in Pharmacological Sciences. 31(2). 74–81. 52 indexed citations

11.

Paxton, Lynn, Tony Hope, & Harold W. Jaffe. (2007). Pre-exposure prophylaxis for HIV infection: what if it works?. The Lancet. 370(9581). 89–93. 69 indexed citations

12.

Santibañez, Scott, et al.. (2006). Update and Overview of Practical Epidemiologic Aspects of HIV/AIDS among Injection Drug Users in the United States. Journal of Urban Health. 83(1). 86–100. 72 indexed citations

13.

Garfein, Richard S., et al.. (2003). Rapid increases in HIV rates – Orel Oblast, Russian Federation, 1999-2001. MMWR Morbidity and Mortality Weekly Report. 52(28). 8 indexed citations

14.

Wawer, Maria J., Nelson K. Sewankambo, David Serwadda, et al.. (1999). Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. The Lancet. 353(9152). 525–535. 589 indexed citations breakdown →

15.

Gray, Ronald H., Maria J. Wawer, David Serwadda, et al.. (1998). Population-based study of fertility in women with HIV-1 infection in Uganda. The Lancet. 351(9096). 98–103. 238 indexed citations

16.

Wawer, Maria J., Ronald H. Gray, Nelson K. Sewankambo, et al.. (1998). A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS. 12(10). 1211–1225. 186 indexed citations

17.

Paxton, Lynn, Noah Kiwanuka, Fred Nalugoda, Ronald H. Gray, & Maria J. Wawer. (1998). Community based study of treatment seeking among subjects with symptoms of sexually transmitted disease in rural Uganda. BMJ. 317(7173). 1630–1631. 10 indexed citations

18.

Gray, Ronald H., Maria J. Wawer, David Serwadda, et al.. (1996). Reduced Fertility Among HIV-Infected Women. Results of Cross-Sectional and Prospective Studies in Rural Uganda. 7(5). 3 indexed citations

19.

Paxton, Lynn, Laurence Slutsker, Laura Schultz, et al.. (1996). Imported Malaria in Montagnard Refugees Settling in North Carolina: Implications for Prevention and Control. American Journal of Tropical Medicine and Hygiene. 54(1). 54–57. 27 indexed citations

20.

Paxton, Lynn, et al.. (1954). Group Procedures in Health Education.. Medical officer. 91(4). 40–41.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact